Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.115703 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Christian Menzer und 29 weiteren Autor:innen. Beteiligte Einrichtung: Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partners…. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Melanoma, Mutation, Protein Kinase Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ and University Hospital Heidelberg, Heidelberg, Germa…
- Institute of Medical Informatics, Heidelberg University Hospital, Heidelberg, Germany.
- Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
- Department of Medical Oncology, University Medical Center Utrecht Cancer Center, Utrecht University, Utrecht, the Netherlands.
- Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, and National Center for Tumor Diseases (NCT-West), Camp…
Zitieren
APA
Menzer, C., Dugas-Breit, S., Dugas, M., Blank, C. U., Groen, E. J., Reijers, I., Schlaak, M., Eckardt, J., Suijkerbuijk, K. P. M., Zimmer, L., Johnson, D. B., Franklin, C., Meiss, F., Schilling, B., Meier, F., Gutzmer, R., Thoms, K. M., Haalck, T., Müller, M., …, & Hassel, J. C. (2025). Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115703
Vancouver
Menzer C, Dugas-Breit S, Dugas M, Blank CU, Groen EJ, Reijers I, et al. Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115703
BibTeX
@article{Menzer2025,
author = {Menzer, Christian and Dugas-Breit, Susanne and Dugas, Martin and Blank, Christian U and Groen, Emma J and Reijers, Irene and Schlaak, Max and Eckardt, Julia and Suijkerbuijk, Karijn P M and Zimmer, Lisa and Johnson, Douglas B and Franklin, Cindy and Meiss, Frank and Schilling, Bastian and Meier, Friedegund and Gutzmer, Ralf and Thoms, Kai-Martin and Haalck, Thomas and Müller, Marilena and Kopp-Schneider, Annette and Carlino, Matteo S and Long, Georgina V and Menzies, Alexander M and van der Veldt, Astrid A M and de Groot, Jan Willem B and Eigentler, Thomas and Stevense-den Boer, Marion and Pföhler, Claudia and Herbschleb, Karin and Hassel, Jessica C},
title = {Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.115703}
}
EUVIMED